Psychedelic Experiences and the Enactive Approach
Daniel Meling, Milan Scheidegger
The Oxford Handbook of Psychedelic, Religious, Spiritual, and Mystical Experiences May 22, 2024 DOI: 10.1093/oxfordhb/9780192844064.013.9 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Citations | 2 |
| Key points | Argues that an enactive approach to psychedelic experiences moves beyond realist and idealist views by emphasizing observer relativity and context dependency. |
Abstract
Abstract Two views on psychedelic experiences include realism and idealism. While a realist view suggests that psychedelic experiences reveal a pre-given world to us, an idealist view suggests they are mere projections of a pre-given mind. This chapter highlights and contrasts their common tendency towards grasping and representations. It presents a promising alternative that aims at going beyond grasping and representations: an enactive approach to psychedelic experiences. It argues that the enactive approach contributes a perspective on psychedelic experiences that leaves behind the assumption of a foundation in either the world or the self and emphasizes both the observer relativity and context dependency involved in psychedelic experiences. It concludes with implications of the enactive perspective for the common core approach to PRSM experiences, the relevance of hallucinogens for the enactive approach, and the authors’ view on the relation between direct experience and belief.
Citations in the library
Cited by 2
- Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat Journal of Psychopharmacology September 27, 2024
- From flow to mystical experiences: Connecting entropy and fluency along the unifying framework of cognitive continuum Philosophical Psychology December 16, 2025
Cites 34
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 29 more in the library